Research ID
hum0222-v1Release info
Research title
Identification of responsible genes and development of standardized medicine for familial breast cancer by genetic analysis with NGS technology
Research overview
- Aims
- To clarify risk of germline variants of known causal genes for Hereditary Breast Ovarian Cancer Syndrome in Japan by combinatorial analysis of somatic and germline variants in the breast cancer tissue.
- Methods
- Target caputure analysis by using Illumina HiSeq 2000
- Participants/materials
- 108 whole blood and 124 primary tumor samples from familial breast cancer patients
- URL
- N/A
Datasets
| Cart | Dataset ID | Type of data | Analysis method | Access criteria | Date published |
|---|---|---|---|---|---|
| JGAD000315 | NGS (Target Capture) |
| Controlled-access (Type I) | 2020-09-28 |
Data provider
- Principal investigator
- Shinji Ohno
- Affiliation
- The Cancer Institute Hospital of JFCR
Research projects
No research projects.
Grants
| Name | Title | Project number |
|---|---|---|
Project for Cancer Research and Therapeutic Evolution (P-CREATE), Japan Agency for Medical Research and Development (AMED) | Identification of responsible genes and development of standardized medicine for familial breast cancer by genetic analysis with NGS technology |
|
Related publications
| Title | DOI | Dataset ID |
|---|---|---|
Prevalence of disease-causing genes in Japanese patients with BRCA1/2-wildtype hereditary breast and ovarian cancer syndrome |
Controlled access users
No use of the controlled access data has been recorded.